Long‐term outcomes of high‐dose (74 GyE ) proton beam therapy with concurrent chemotherapy for stage III nonsmall‐cell lung cancer-Reference-Cited by-同舟云学术

Long‐term outcomes of high‐dose (74 GyE ) proton beam therapy with concurrent chemotherapy for stage III nonsmall‐cell lung cancer

Published:2021-03-06 Issue:9 Volume:12 Page:1320-1327
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thoracic Cancer

Author:

Ohnishi Kayoko¹²^ORCID,Ishikawa Hitoshi¹³,Nakazawa Kensuke⁴,Shiozawa Toshihiro⁴,Mori Yutaro¹,Nakamura Masatoshi¹,Okumura Toshiyuki¹,Sekine Ikuo⁵,Hizawa Nobuyuki⁴,Sakurai Hideyuki¹

Affiliation:

1. Department of Radiation Oncology, Faculty of Medicine University of Tsukuba Tsukuba Japan

2. Department of Radiology, School of Medicine International University of Health and Welfare Narita Japan

3. QST Hospital National Institutes for Quantum and Radiological Science and Technology Chiba Japan

4. Department of Respiratory Medicine, Faculty of Medicine University of Tsukuba Tsukuba Japan

5. Department of Medical Oncology, Faculty of Medicine University of Tsukuba Tsukuba Japan

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.13896

Reference33 articles.

1. Improved Survival in Stage III Non-Small-Cell Lung Cancer: Seven-Year Follow-up of Cancer and Leukemia Group B (CALGB) 8433 Trial

2. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non‐small‐cell lung cancer;Furuse K;J Clin Oncol,1999

3. A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung. Preliminary report by the radiation therapy oncology group

4. Primary Analysis of the Phase II Component of a Phase I/II Dose Intensification Study Using Three-Dimensional Conformal Radiation Therapy and Concurrent Chemotherapy for Patients With Inoperable Non–Small-Cell Lung Cancer: RTOG 0117

5. A Phase I/II Radiation Dose Escalation Study With Concurrent Chemotherapy for Patients With Inoperable Stages I to III Non-Small-Cell Lung Cancer: Phase I Results of RTOG 0117

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long‐term follow‐up of unresectable adenoid cystic carcinoma of the trachea and bronchus treated with high‐dose proton beam therapy: A report of two cases;Thoracic Cancer;2023-11-20

2. Efficacy and safety of particle therapy for inoperable stage II-III non-small cell lung cancer: a systematic review and meta-analysis;Radiation Oncology;2023-05-22

3. Effects of lymphopenia on survival in proton therapy with chemotherapy for non-small cell lung cancer;Journal of Radiation Research;2023-01-02

4. Treatment of Stage III Non-small Cell Lung Cancer;Respiratory Medicine;2023

5. Radiation induced lung injury (RILI) after postoperative intensity modulated proton therapy (IMPT) in a patient with stage III locally advanced lung adenocarcinoma: a case report;Translational Cancer Research;2022-09